Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR5A1 | Q13285 | 1/20 | 0.45 |
| ▸ | CNR2 | P34972 | 10/20 | 0.44 |
| ▸ | CNR1 | P21554 | 8/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | TYR | P14679 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.43 |
| ▸ | CYSLTR2 | Q9NS75 | 1/20 | 0.43 |
| ▸ | CYSLTR1 | Q9Y271 | 1/20 | 0.43 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.42 |
| ▸ | PGAM1 | P18669 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11329254 | 0.78 | SMPD1 (0.60) | NR5A1CNR2CNR1MEN1TP53 | |
| SCHEMBL28095186 | 0.78 | NR5A1 (0.58) | NR5A1CNR2CNR1MEN1TP53 | |
| SCHEMBL14557522 | 0.78 | SMPD1 (0.60) | NR5A1CNR2CNR1MEN1TP53 | |
| SCHEMBL7068652 | 0.78 | TRPV4 (0.45) | MAPTTSHRHTTTDP1 | |
| SCHEMBL30528065 | 0.76 | SMPD1 (0.57) | NR5A1CNR2CNR1MEN1TP53 | |
| SCHEMBL1405908 | 0.76 | SMPD1 (0.57) | NR5A1CNR2CNR1MEN1TP53 | |
| SCHEMBL19433097 | 0.76 | NR5A1 (0.55) | NR5A1CNR2MEN1TP53CYP3A4 | |
| SCHEMBL9698493 | 0.76 | NR5A1 (0.51) | NR5A1CNR2CNR1HTTCYSLTR2 | |
| SCHEMBL10600672 | 0.75 | CYP1A2 (0.43) | ALOX5 | |
| SCHEMBL27639403 | 0.74 | TRPV1 (0.49) | MEN1TP53CYP3A4ALOX5MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8859819-B2 | Sulphurated derivatives of resorcinol, preparation of same and cosmetic uses thereof | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2014-10-14 | — | — | US | claimed |
| EP-2417104-A1 | SULPHURATED DERIVATIVES OF RESORCINOL, PREPARATION OF SAME AND COSMETIC USES THEREOF | Pierre Fabre Dermo-Cosmétique (FR) | 2012-02-15 | — | — | EP | claimed |
| US-20120034176-A1 | SULPHURATED DERIVATIVES OF RESORCINOL, PREPARATION OF SAME AND COSMETIC USES THEREOF | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2012-02-09 | — | — | US | claimed |
| WO-2010115945-A1 | SULPHURATED DERIVATIVES OF RESORCINOL, PREPARATION OF SAME AND COSMETIC USES THEREOF | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2010-10-14 | — | — | WO | claimed |
| US-8859819-B2 | Sulphurated derivatives of resorcinol, preparation of same and cosmetic uses thereof | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2014-10-14 | — | — | US | disclosed |
| US-8859819-B2 | Sulphurated derivatives of resorcinol, preparation of same and cosmetic uses thereof | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2014-10-14 | — | — | US | disclosed |
| US-8859819-B2 | Sulphurated derivatives of resorcinol, preparation of same and cosmetic uses thereof | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2014-10-14 | — | — | US | disclosed |
| EP-2417104-A1 | SULPHURATED DERIVATIVES OF RESORCINOL, PREPARATION OF SAME AND COSMETIC USES THEREOF | Pierre Fabre Dermo-Cosmétique (FR) | 2012-02-15 | — | — | EP | disclosed |
| US-20120034176-A1 | SULPHURATED DERIVATIVES OF RESORCINOL, PREPARATION OF SAME AND COSMETIC USES THEREOF | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2012-02-09 | — | — | US | disclosed |
| US-20120034176-A1 | SULPHURATED DERIVATIVES OF RESORCINOL, PREPARATION OF SAME AND COSMETIC USES THEREOF | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2012-02-09 | — | — | US | disclosed |
| US-20120034176-A1 | SULPHURATED DERIVATIVES OF RESORCINOL, PREPARATION OF SAME AND COSMETIC USES THEREOF | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2012-02-09 | — | — | US | disclosed |
| WO-2010115945-A1 | SULPHURATED DERIVATIVES OF RESORCINOL, PREPARATION OF SAME AND COSMETIC USES THEREOF | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2010-10-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120034176-A1 | SULPHURATED DERIVATIVES OF RESORCINOL, PREPARATION OF SAME AND COSMETIC USES THEREOF | CBR3, ACSL3, MSRB3 | NR5A1 704/4885CNR2 1629/4885CNR1 1386/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.